(HealthDay)—Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome...

During my daughter’s challenging first year of school, we discovered how much effort it took her to sit and learn. She was the youngest in her class, placing her at higher risk of being diagnosed...